» Articles » PMID: 36697975

Trends in Obesity Prevalence and Cardiometabolic Risk Factor Control in US Adults with Diabetes, 1999-2020

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Trends in obesity prevalence and trends in control of cardiometabolic risk factors among National Health and Nutrition Examination Survey participants with diabetes from 1999 through 2020 were analyzed.

Methods: Adults who were 20 years or older and who reported having received a diagnosis of diabetes from a physician were included.

Results: The prevalence of overall obesity, obesity class II, and obesity class III increased from 46.9%, 14.1%, and 10.3% in 1999 to 2002 to 58.1%, 16.6%, and 14.8% in 2015 to 2020, respectively. The prevalence of participants who achieved glycemic control (HbA1c <7%) increased from 42.5% in 1999 to 2002 to 51.8% in 2007 to 2010, then decreased to 48.0% in 2015 to 2020. The prevalence of participants who achieved blood pressure control (<140/90 mmHg) or achieved non-high-density lipoprotein cholesterol control (<130 mg/dL) increased throughout the study periods. The prevalence of participants who met all three risk factor goals increased from 8.3% in 1999 to 2002 to 21.2% in 2011 to 2014 and then decreased to 18.5 in 2015 to 2020. Participants with obesity showed worsening glycemic control and lipid control than participants with normal weight.

Conclusions: There were increasing trends in prevalence of obesity, blood pressure control, and lipid control from 1999 to 2002 to 2015 to 2020. Participants with obesity showed worsening glycemic control and lipid control than normal-weight participants.

Citing Articles

Fifteen-year trends in diabetes drug management and control in French-speaking Switzerland.

Pauli A, Alkandari A, Marques-Vidal P Diabetol Metab Syndr. 2025; 17(1):56.

PMID: 39940012 PMC: 11823013. DOI: 10.1186/s13098-025-01620-z.


Newer pharmacological interventions directed at gut hormones for obesity.

Camilleri M, Acosta A Br J Pharmacol. 2023; 181(8):1153-1164.

PMID: 37917871 PMC: 10947960. DOI: 10.1111/bph.16278.


Cross-walk of the Chronic Liver Disease Questionnaire for Nonalcoholic Steatohepatitis (CLDQ-NASH) and the EuroQol EQ-5D-5L in patients with NASH.

Fishman J, Higgins V, Piercy J, Pike J Health Qual Life Outcomes. 2023; 21(1):113.

PMID: 37838660 PMC: 10576276. DOI: 10.1186/s12955-023-02195-x.


Obesity, Cardiorespiratory Fitness, and Cardiovascular Disease.

Haidar A, Horwich T Curr Cardiol Rep. 2023; 25(11):1565-1571.

PMID: 37831388 PMC: 10682063. DOI: 10.1007/s11886-023-01975-7.

References
1.
Li W, Katzmarzyk P, Horswell R, Zhang Y, Zhao W, Wang Y . Body mass index and stroke risk among patients with type 2 diabetes mellitus. Stroke. 2014; 46(1):164-9. PMC: 4276457. DOI: 10.1161/STROKEAHA.114.006718. View

2.
Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K . Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med. 2004; 164(10):1066-76. DOI: 10.1001/archinte.164.10.1066. View

3.
Flegal K, Kruszon-Moran D, Carroll M, Fryar C, Ogden C . Trends in Obesity Among Adults in the United States, 2005 to 2014. JAMA. 2016; 315(21):2284-91. PMC: 11197437. DOI: 10.1001/jama.2016.6458. View

4.
. Effects of Intensive Lifestyle Intervention on All-Cause Mortality in Older Adults With Type 2 Diabetes and Overweight/Obesity: Results From the Look AHEAD Study. Diabetes Care. 2022; . PMC: 9174966. DOI: 10.2337/dc21-1805. View

5.
Jensen M, Ryan D, Apovian C, Ard J, Comuzzie A, Donato K . 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2013; 129(25 Suppl 2):S102-38. PMC: 5819889. DOI: 10.1161/01.cir.0000437739.71477.ee. View